MicroRNA-191 promotes osteosarcoma cells proliferation by targeting checkpoint kinase 2

被引:31
作者
Huang, Ya-Zeng [1 ]
Zhang, Jun [1 ]
Shao, Hai-Yu [1 ]
Chen, Jin-Ping [1 ]
Zhao, Hong-Ying [2 ]
机构
[1] Zhejiang Prov Peoples Hosp, Dept Orthopaed, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Dept Pharm, Hangzhou, Zhejiang, Peoples R China
关键词
Osteosarcoma; MicroRNA; miR-191; Chk2; DNA-DAMAGE; BREAST-CANCER; CARCINOMA; CHEK2; OVEREXPRESSION; EXPRESSION; MUTATIONS; MECHANISM; MIR-191; GENOME;
D O I
10.1007/s13277-015-3290-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
MicroRNAs (miRNAs) are small noncoding RNAs of 19-25 nt that can regulate gene expression at a posttranscriptional level. Increasing evidence indicates that miRNAs participate in almost every step of cellular processes and are often aberrantly expressed in human cancer. The aim of this study was to investigate the functional significance of miR-191 and to identify its possible target genes in osteosarcoma cells. Here, we found that the expression level of miR-191 was increased in osteosarcoma tissues in comparison with the adjacent normal tissues. The enforced expression of miR-191 was able to promote cell proliferation in Saos-2 and MG62 cells, while miR-191 antisense oligonucleotides blocked cell proliferation. At the molecular level, our results further revealed that expression of tumor suppressor gene, checkpoint kinase 2, was negatively regulated by miR-191. Therefore, we consider that miR-191 act as an onco-MicroRNA for osteosarcoma and it would offer a new way in molecular targeting cancer treatment.
引用
收藏
页码:6095 / 6101
页数:7
相关论文
共 27 条
[1]
CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin? [J].
Antoni, Laurent ;
Sodha, Nayanta ;
Collins, Ian ;
Garrett, Michelle D. .
NATURE REVIEWS CANCER, 2007, 7 (12) :925-936
[2]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]
Regional Activation of the Cancer Genome by Long-Range Epigenetic Remodeling [J].
Bert, Saul A. ;
Robinson, Mark D. ;
Strbenac, Dario ;
Statham, Aaron L. ;
Song, Jenny Z. ;
Hulf, Toby ;
Sutherland, Robert L. ;
Coolen, Marcel W. ;
Stirzaker, Clare ;
Clark, Susan J. .
CANCER CELL, 2013, 23 (01) :9-22
[4]
The evolution of gene regulation by transcription factors and microRNAs [J].
Chen, Kevin ;
Rajewsky, Nikolaus .
NATURE REVIEWS GENETICS, 2007, 8 (02) :93-103
[5]
Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016
[6]
Mutations in CHEK2 associated with prostate cancer risk [J].
Dong, XY ;
Wang, L ;
Taniguchi, K ;
Wang, XS ;
Cunningham, JM ;
McDonnell, SK ;
Qian, CP ;
Marks, AF ;
Slager, SL ;
Peterson, BJ ;
Smith, BI ;
Cheville, JC ;
Blute, ML ;
Jacobsen, SJ ;
Schaid, DJ ;
Tindall, DJ ;
Thibodeau, SN ;
Liu, WG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (02) :270-280
[7]
Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[8]
Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway [J].
Falck, J ;
Lukas, C ;
Protopopova, M ;
Lukas, J ;
Selivanova, G ;
Bartek, J .
ONCOGENE, 2001, 20 (39) :5503-5510
[9]
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia [J].
Garzon, Ramiro ;
Volinia, Stefano ;
Liu, Chang-Gong ;
Fernandez-Cymering, Cecilia ;
Palumbo, Tiziana ;
Pichiorri, Flavia ;
Fabbri, Muller ;
Coombes, Kevin ;
Alder, Hansjuerg ;
Nakamura, Tatsuya ;
Flomenberg, Neal ;
Marcucci, Guido ;
Calin, George A. ;
Kornblau, Steven M. ;
Kantarjian, Hagop ;
Bloomfield, Clara D. ;
Andreeff, Michael ;
Croce, Carlo M. .
BLOOD, 2008, 111 (06) :3183-3189
[10]
Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma [J].
Hauser, Stefan ;
Wulfken, Lena M. ;
Holdenrieder, Stefan ;
Moritz, Rudolf ;
Ohlmann, Carsten-Henning ;
Jung, Volker ;
Becker, Frank ;
Herrmann, Edwin ;
Walgenbach-Bruenagel, Gisela ;
von Ruecker, Alexander ;
Mueller, Stefan C. ;
Ellinger, Joerg .
CANCER EPIDEMIOLOGY, 2012, 36 (04) :391-394